Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Hugh Q. Zhao"'
Publikováno v:
Bioactive Materials, Vol 17, Iss , Pp 488-495 (2022)
Biliary stricture is defined as the reduction and narrowing of the bile duct lumen, which can be caused by many factors such as cancer and inflammation. Biliary stent placement can effectively alleviate benign and malignant biliary strictures. Howeve
Externí odkaz:
https://doaj.org/article/baae93038cd2427ea1ef37d45ab03afc
Autor:
Stephen D. Pacetti, Alexander Nikanorov, Elazer R. Edelman, Vijaya B. Kolachalama, John Stankus, Joseph W. Franses, Tarek Shazly, Lewis B. Schwartz, Abraham R. Tzafriri, Hugh Q. Zhao
Publikováno v:
PMC
Background—Drug-coated balloons are increasingly used for peripheral vascular disease, and, yet, mechanisms of tissue uptake and retention remain poorly characterized. Most systems to date have used paclitaxel, touting its propensity to associate w
Publikováno v:
Journal of Biomedical Materials Research Part A. :877-887
A microporous and permeable wall is important for the healing of vascular prostheses, however, the significance of its permeability to soluble substances at subcellular level has not been demonstrated. Polyester arterial prostheses were prepared in s
Publikováno v:
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 9(6)
The purpose of this prospective clinical investigation was to quantify the degree and range of compressive and bending deformations sustained by self-expanding nitinol stents when implanted into the femoropopliteal arteries of patients with symptomat
Publikováno v:
Journal of biomedical materials research. Part A. 100(1)
The time-dependent local drug delivery from drug-eluting stents (DES) plays a critical role in reducing restenosis in intravascular stenting. To better understand the basic mechanism of drug release for certain polymer-drug-coated DES platforms, a cy
Publikováno v:
Journal of Vascular Surgery. (6):1680-1688
IntroductionA novel self-expanding, drug-eluting stent (DES) was designed to slowly release everolimus in order to prevent restenosis after percutaneous peripheral intervention. The purpose of this experimental animal study was to test the hypothesis